Intestinal inflammation in cystic fibrosis

BACKGROUND There is controversy about whether the inflammatory response observed in the cystic fibrosis (CF) lung occurs secondary to bacterial infection or is caused by a dysregulation of the inflammatory response associated with the basic cellular defect of CF. AIMS To study the inflammatory response in the gastrointestinal tract of children with CF; and to investigate whether there is increased inflammation in the gastrointestinal tract of CF children with fibrosing colonopathy. METHODS Whole gut lavage was performed on 21 pancreatic insufficient children with CF, who were clinically well, five children with CF and fibrosing colonopathy, and 12 controls. Intestinal outputs of plasma derived proteins (albumin, α1 antitrypsin, IgG), secretory immunoglobulins (IgA and IgM), cellular constituents (eosinophil cationic protein and neutrophil elastase), and cytokines (interleukin 8 and interleukin 1β) were measured. RESULTS Compared to controls, the 21 CF patients, with no intestinal complications, had increased intestinal outputs of albumin, IgG, IgM, eosinophil cationic protein, neutrophil elastase, interleukin 1β, and interleukin 8. Similar values were obtained for the CF patients with fibrosing colonopathy. CONCLUSIONS These data suggest that there is immune activation in the gastrointestinal mucosa of children with cystic fibrosis, which may result from the basic cellular defect. Fibrosing colonopathy does not appear to be associated with increased inflammation.

[1]  I. Bjarnason,et al.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. , 2000, Gastroenterology.

[2]  V. Raia,et al.  Evidence of Chronic Inflammation in Morphologically Normal Small Intestine of Cystic Fibrosis Patients , 2000, Pediatric Research.

[3]  N. Croft.  High Intraluminal Fluid Flow Increases Intestinal IgA Output , 2000, Scandinavian journal of gastroenterology.

[4]  L. Greco,et al.  Increased concentrations of eosinophilic cationic protein in whole-gut lavage fluid from children with inflammatory bowel disease. , 1999, Journal of pediatric gastroenterology and nutrition.

[5]  L. Greco,et al.  Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease. , 1997, Gut.

[6]  R. Frizzell,et al.  Cystic fibrosis gene mutation (deltaF508) is associated with an intrinsic abnormality in Ca2+-induced arachidonic acid release by epithelial cells. , 1997, DNA and cell biology.

[7]  V. Raia,et al.  DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? , 1997, FEBS letters.

[8]  D. Porteous,et al.  Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. , 1997, The American journal of physiology.

[9]  T. Noah,et al.  Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. , 1997, The Journal of infectious diseases.

[10]  D. Koller,et al.  Relationship between disease severity and inflammatory markers in cystic fibrosis. , 1996, Archives of disease in childhood.

[11]  A. Ferguson,et al.  Investigation of neutrophils in the gut lumen by assay of granulocyte elastase in whole-gut lavage fluid. , 1996, Scandinavian journal of gastroenterology.

[12]  A. Ferguson,et al.  Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis. , 1996, Postgraduate medical journal.

[13]  A. Ferguson,et al.  Clinical investigation of gut immune responses. , 1995 .

[14]  M. Konstan,et al.  Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.

[15]  A. Ferguson,et al.  Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements , 1995, The Lancet.

[16]  D. Ashby,et al.  Fibrosing colonopathy in cystic fibrosis: results of a case-control study , 1995, The Lancet.

[17]  M. Weinberger,et al.  The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis , 1995, Pediatric pulmonology.

[18]  J. Warner,et al.  Faecal interleukin-8 and tumour necrosis factor-alpha concentrations in cystic fibrosis. , 1995, Archives of disease in childhood.

[19]  P. Phelan,et al.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis , 1995, BMJ.

[20]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[21]  A. Cantin,et al.  Cystic fibrosis lung inflammation: early, sustained, and severe. , 1995, American journal of respiratory and critical care medicine.

[22]  M. Konstan,et al.  Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. , 1994, American journal of respiratory and critical care medicine.

[23]  R. Crystal,et al.  Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. , 1994, American journal of respiratory and critical care medicine.

[24]  D. Koller,et al.  Eosinophilic activation in cystic fibrosis. , 1994, Thorax.

[25]  J. Warner,et al.  Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic Fibrosis , 1993, Pediatric Research.

[26]  S. Elsayed,et al.  Increased fecal eosinophil cationic protein in inflammatory bowel disease. , 1993, Hepato-gastroenterology.

[27]  A. Ferguson,et al.  Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease. , 1993, Gastroenterology.

[28]  R. Crystal,et al.  Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. , 1992, The Journal of clinical investigation.

[29]  W. Calhoun,et al.  Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. , 1991, The American review of respiratory disease.

[30]  D. Norman,et al.  Inflammatory markers in cystic fibrosis. , 1991, Respiratory medicine.

[31]  J. Barton,et al.  Dissociation between systemic and mucosal humoral immune responses in coeliac disease. , 1991, Gut.

[32]  J. Barton,et al.  Appraisal of gut lavage in the study of intestinal humoral immunity. , 1990, Gut.

[33]  S. Douglas,et al.  Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. , 1990, The American review of respiratory disease.

[34]  S. Suter,et al.  Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. , 1989, The American review of respiratory disease.

[35]  D. Delacroix,et al.  Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? , 1987, Annals of internal medicine.

[36]  H. Shwachman,et al.  Disaccharidase activities in small intestinal mucosa in patients with cystic fibrosis. , 1978, The Journal of pediatrics.

[37]  C. Roy,et al.  Small bowel mucosal dysfunction in patients with cystic fibrosis. , 1976, The Journal of pediatrics.

[38]  L. Taussig,et al.  IgA synthesis by jejunal biopsies from patients with cystic fibrosis and hereditary pancreatitis. , 1973, Pediatrics.

[39]  H. B. Freye,et al.  LIGHT AND ELECTRON MICROSCOPIC EXAMINATION OF THE SMALL BOWEL OF CHILDREN WITH CYSTIC FIBROSIS. , 1964, The Journal of pediatrics.

[40]  C. Anderson,et al.  Bacterial Content of Small Intestine of Children in Health, in Coeliac Disease, and in Fibrocystic Disease of Pancreas , 1958, British medical journal.